Table 2.
Baseline characteristics | No delirium (N = 153) | Delirium (N = 230) | p-value |
---|---|---|---|
Age | 68.1 (56.9–76.0) | 73.2 (62.4–80.1) | 0.001 |
Female | 49 (32.0%) | 74 (32.2%) | 0.976 |
Comorbidities | |||
Coronary heart disease | 40 (26.1%) | 68 (29.6%) | 0.466 |
Heart rhythm disturbances | 30 (19.6%) | 87 (37.8%) | < 0.001 |
Obesity | 24 (15.7%) | 36 (15.7%) | 0.993 |
Pulmonary disease | 31 (20.3%) | 44 (19.1%) | 0.785 |
Liver disease | 15 (9.8%) | 28 (12.2%) | 0.472 |
Chronic kidney disease | 55 (35.9%) | 87 (37.8%) | 0.709 |
Peripherial/cerebral arterial occlusive disease | 16 (10.5%) | 32 (13.9%) | 0.317 |
Neurological disease | 23 (15.0%) | 62 (27.0%) | 0.006 |
Malignancy | 33 (21.6%) | 37 (16.1%) | 0.174 |
Psychiatric disease/dementia | 6 (3.9%) | 41 (17.8%) | < 0.001 |
Alcohol abuse | 6 (3.9%) | 25 (10.9%) | 0.015 |
Drug abuse | 2 (1.3%) | 9 (3.9%) | 0.135 |
p value reported in bold if difference is significant (p < 0.05). Data are given as median and interquartile range (25th–75th) or number of patients (percent of all patients in group).